Actigen™ is a second generation, unique bioactive fraction derived from the outer cell wall of a specific strain of yeast, Saccharomyces cerevisiae, where it acts in the gut to bind pathogenic bacteria, preventing disease and competition for nutrients. In the current trial, 260 sows were used and fed either an unsupplemented control diet or one containing Actigen™ at 0.08% of the formulation during gestation, farrowing and lactation, to assess its impact on sow and piglet performance. Results showed significant increases in feed intake for sows fed Actigen™ pre-farrowing, but this was reversed during lactation, leading to a 7 kg saving in feed intake per animal. At birth, piglets weighed 42 g more in litters from Actigen™-fed sows compared to the control group. Weaning weight of the total litter from Actigen™ sows was significantly higher (P< 0.05) by 3.3 kg, although individual piglet weights were the same. Sows showed no significant loss in body weight during the trial, indicating that the improved piglet production was related to improved nutrient availability and perhaps Ig status of piglets due to the addition of Actigen™ in the diet.